THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $137,000 | -57.3% | 18,482 | +2.4% | 0.01% | -42.9% |
| Q4 2020 | $321,000 | -79.2% | 18,051 | -75.5% | 0.01% | -82.3% |
| Q2 2020 | $1,546,000 | +64.6% | 73,667 | +81.4% | 0.08% | +16.2% |
| Q1 2020 | $939,000 | +1.5% | 40,621 | +13.7% | 0.07% | +65.9% |
| Q4 2019 | $925,000 | +70.7% | 35,735 | +28.3% | 0.04% | +46.4% |
| Q3 2019 | $542,000 | -21.9% | 27,844 | -34.4% | 0.03% | -26.3% |
| Q2 2019 | $694,000 | +4.8% | 42,471 | +109.6% | 0.04% | -25.5% |
| Q3 2018 | $662,000 | – | 20,262 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |